Digital PCR (dPCR) instrumentation, on the other hand, represents an emerging market. Continuous technology developments are helping lower costs and increase market penetration of dPCR tools. Key benefits of dPCR responsible for driving its adoption in the medical research space include ability to conduct hundreds of PCR amplifications on a single sample; high performance, superior specificity, sensitivity, precision, and robustness; ability to perform absolute quantification at lower costs; and developments in microfluidic tools that help complement the use of dPCR. Clinical laboratories are forecast emerge as a promising end-use market for dPCR platforms in the coming years. dPCR is also expected to find special adoption in the field of cancer research supported by the technology’s unrivalled levels of precision in quantifying cancer-causing genes. Other emerging application areas for dPCR include next-generation sequencing (NGS), identification of rare mutations in genes, gene expression and miRNA analysis, single cell analysis, and pathogen detection.
The study estimates the global qPCR and dPCR Instrumentation market to be a multi-million dollar market, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.
The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights inc
Copyright©2012 Vocus, Inc.
All rights reserved